These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12416746)

  • 41. Evaluation of colonic sensory thresholds in IBS patients using a barostat. Definition of optimal conditions and comparison with healthy subjects.
    Bradette M; Delvaux M; Staumont G; Fioramonti J; Bueno L; Frexinos J
    Dig Dis Sci; 1994 Mar; 39(3):449-57. PubMed ID: 8131679
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regional brain activation in response to rectal distension in patients with irritable bowel syndrome and the effect of a history of abuse.
    Ringel Y; Drossman DA; Turkington TG; Bradshaw B; Hawk TC; Bangdiwala S; Coleman RE; Whitehead WE
    Dig Dis Sci; 2003 Sep; 48(9):1774-81. PubMed ID: 14561000
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Altered esophageal pain threshold in irritable bowel syndrome.
    Costantini M; Sturniolo GC; Zaninotto G; D'Incà R; Polo R; Naccarato R; Ancona E
    Dig Dis Sci; 1993 Feb; 38(2):206-12. PubMed ID: 8093869
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bloating and distension in irritable bowel syndrome: the role of gastrointestinal transit.
    Agrawal A; Houghton LA; Reilly B; Morris J; Whorwell PJ
    Am J Gastroenterol; 2009 Aug; 104(8):1998-2004. PubMed ID: 19491831
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sensitivity and distensibility of the rectum and sigmoid colon in patients with irritable bowel syndrome.
    Drewes AM; Petersen P; Rössel P; Gao C; Hansen JB; Arendt-Nielsen L
    Scand J Gastroenterol; 2001 Aug; 36(8):827-32. PubMed ID: 11495078
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome.
    Prather CM; Camilleri M; Zinsmeister AR; McKinzie S; Thomforde G
    Gastroenterology; 2000 Mar; 118(3):463-8. PubMed ID: 10702196
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Altered rectal perception in irritable bowel syndrome is associated with symptom severity.
    Posserud I; Syrous A; Lindström L; Tack J; Abrahamsson H; Simrén M
    Gastroenterology; 2007 Oct; 133(4):1113-23. PubMed ID: 17919487
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An exaggerated sensory component of the gastrocolonic response in patients with irritable bowel syndrome.
    Simrén M; Abrahamsson H; Björnsson ES
    Gut; 2001 Jan; 48(1):20-7. PubMed ID: 11115818
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cholecystokinin octapeptide increases rectal sensitivity to pain in healthy subjects.
    Sabaté JM; Gorbatchef C; Flourié B; Jian R; Coffin B
    Neurogastroenterol Motil; 2002 Dec; 14(6):689-95. PubMed ID: 12464091
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influence of continuous isobaric rectal distension on gastric emptying and small bowel transit in young healthy women.
    Coremans G; Geypens B; Vos R; Tack J; Margaritis V; Ghoos Y; Janssens J
    Neurogastroenterol Motil; 2004 Feb; 16(1):107-11. PubMed ID: 14764210
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of sex on perception of rectosigmoid stimuli in irritable bowel syndrome.
    Chang L; Mayer EA; Labus JS; Schmulson M; Lee OY; Olivas TI; Stains J; Naliboff BD
    Am J Physiol Regul Integr Comp Physiol; 2006 Aug; 291(2):R277-84. PubMed ID: 16574882
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relation of colonic transit to functional bowel disease in older people: a population-based study.
    Evans JM; Fleming KC; Talley NJ; Schleck CD; Zinsmeister AR; Melton LJ
    J Am Geriatr Soc; 1998 Jan; 46(1):83-7. PubMed ID: 9434670
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gastrointestinal motility in patients with the irritable bowel syndrome.
    Abrahamsson H
    Scand J Gastroenterol Suppl; 1987; 130():21-6. PubMed ID: 3477013
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vagal dysfunction in irritable bowel syndrome assessed by rectal distension and baroreceptor sensitivity.
    Spaziani R; Bayati A; Redmond K; Bajaj H; Mazzadi S; Bienenstock J; Collins SM; Kamath MV
    Neurogastroenterol Motil; 2008 Apr; 20(4):336-42. PubMed ID: 18179607
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interactions between symptoms and motor and visceral sensory responses of irritable bowel syndrome patients to spasmolytics (antispasmodics).
    Khalif IL; Quigley EM; Makarchuk PA; Golovenko OV; Podmarenkova LF; Dzhanayev YA
    J Gastrointestin Liver Dis; 2009 Mar; 18(1):17-22. PubMed ID: 19337628
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Study of visceral hypersensitivity in irritable bowel syndrome.
    Dong WZ; Zou DW; Li ZS; Zou XP; Zhu AY; Xu GM; Yin N; Gong YF; Sun ZX; Man XH
    Chin J Dig Dis; 2004; 5(3):103-9. PubMed ID: 15612244
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chili pepper and rectal hyperalgesia in irritable bowel syndrome.
    Schmulson MJ; Valdovinos MA; Milke P
    Am J Gastroenterol; 2003 May; 98(5):1214-5. PubMed ID: 12809862
    [No Abstract]   [Full Text] [Related]  

  • 58. Rectal afferent hypersensitivity and compliance in irritable bowel syndrome: differences between diarrhoea-predominant and constipation-predominant subgroups.
    Zar S; Benson MJ; Kumar D
    Eur J Gastroenterol Hepatol; 2006 Feb; 18(2):151-8. PubMed ID: 16394796
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lower functional gastrointestinal disorders: evidence of abnormal colonic transit in a 287 patient cohort.
    Manabe N; Wong BS; Camilleri M; Burton D; McKinzie S; Zinsmeister AR
    Neurogastroenterol Motil; 2010 Mar; 22(3):293-e82. PubMed ID: 20025692
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Selective 5-hydroxytryptamine type 3 receptor antagonism with ondansetron as treatment for diarrhea-predominant irritable bowel syndrome: a pilot study.
    Steadman CJ; Talley NJ; Phillips SF; Zinsmeister AR
    Mayo Clin Proc; 1992 Aug; 67(8):732-8. PubMed ID: 1434911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.